SDG Collaborations

ARC

ARC

Research Arc - Academic Research & Collaboration

All rights are reserved, including rights for text and data mining, AI training, and similar technologies.

Quick Links

Profiles Research Outputs Publications Projects Research Areas Patents SDG Collaborations

Copyright 2026 © ARC is a product of SparkLab Information Technologies Inc.. All rights reserved.

MELEK ERDEM

Doctor Faculty Member

İstinye Üniversitesi

Faculty of Medicine

Department of Pediatrics

melek.erdem@istinye.edu.tr

iDORCID0000-0002-1000-7201

YÖKYÖKID158164

SCSCOPUSID58344365100

WoSWOSIDAAI-9197-2021

Citations

106

H-Index (Scopus)

6

Overview
Curriculum Vitae
Research Areas
Network
Publications
Projects
Courses
Thesis Supervision
Intellectual Property
Awards
Other Activities

Search Publications

Records found: 68

0 active filters

SCScopus

WoS

Impact of clinical pharmacist-led medication management and education on tacrolimus therapeutic control

Ozturk N.

Frontiers in Medicine, 2026

SCArticleQ1Open access

Efficacy of Etoposide-Based Therapy in Pediatric Secondary Hemophagocytic Lymphohistiocytosis

Tahta, N

EUROPEAN JOURNAL OF HAEMATOLOGY, 2026

ArticleQ2Juvenile Arthritis & HLHClinical & Life SciencesRheumatology

Impact of clinical pharmacist-led medication management and education on tacrolimus therapeutic control

Ozturk, N

FRONTIERS IN MEDICINE, 2026

Early Relapse with Isolated Myeloid Sarcoma in a Patient Diagnosed Acute Myeloid Leukemia with FLT3- D835Y Mutation

Oktay B.K.

SN Comprehensive Clinical Medicine, 2025

Can Posttransplant Cyclophosphamide Reduce the Risk of Graft-Versus-Host Disease for Pediatric Fully Matched Nonrelated Stem Cell Transplant?

Aksoy B.A.

Experimental and Clinical Transplantation, 2025

SCArticleQ3Innovations in Donor Selection and GVHD ProphylaxisClostridium Difficile and Stem Cell Transplantation Insights

Can Posttransplant Cyclophosphamide Reduce the Risk of Graft-Versus-Host Disease for Pediatric Fully Matched Nonrelated Stem Cell Transplant?

Aksoy, BA

EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2025

ArticleQ4GvHDClinical & Life SciencesBlood Disorders

Outcomes of Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: How Do Anti-HLA Antibodies Impact?: The Impact of Anti-HLA Antibodies on Transplantation Outcomes in Thalassemia Major

Ersoy G.Z.

Clinical Transplantation, 2024

SCArticleQ2Innovations in Donor Selection and GVHD ProphylaxisClostridium Difficile and Stem Cell Transplantation Insights

Evaluation of bleeding diathesis in patients with Noonan syndrome and comparison with thromboelastography (TEG) test results: A single-center experience

Okur Acar S.

Trends in Pediatrics, 2024

SCArticleQ4Open access

Sirolimus is effective and safe in childhood relapsed-refractory autoimmune cytopenias: A multicentre study

Acar S.O.

Scandinavian Journal of Immunology, 2024

SCArticleQ2Open accessAutoimmune Lymphoproliferative Syndrome MechanismsCell Death Mechanisms in Cancer Progression

Sirolimus is effective and safe in childhood relapsed-refractory autoimmune cytopenias: A multicentre study

Acar, SO

SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2024

Outcomes of Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: How Do Anti-HLA Antibodies Impact?

Ersoy, GZ

CLINICAL TRANSPLANTATION, 2024

ArticleQ2GvHDClinical & Life SciencesBlood Disorders

Evaluation of bleeding diathesis in patients with Noonan syndrome and comparison with thromboelastography (TEG) test results: A single-center experience

Acar, SO

TRENDS IN PEDIATRICS, 2024

Page 1 / 6